Role of Sp proteins in regulation of vascular endothelial growth factor expression and proliferation of pancreatic cancer cells

被引:169
作者
Abdelrahim, M
Smith, R
Burghardt, R
Safe, S
机构
[1] Texas A&M Univ, Dept Vet Physiol & Pharmacol, College Stn, TX 77843 USA
[2] Texas A&M Univ, Dept Vet Pathobiol, College Stn, TX 77843 USA
[3] Texas A&M Univ, Dept Vet Anat & Publ Hlth, College Stn, TX 77843 USA
[4] Texas A&M Univ, Syst Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX USA
关键词
D O I
10.1158/0008-5472.CAN-04-0713
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Sp proteins play an important role in angiogenesis and growth of cancer cells, and specificity protein 1 (Sp1) has been linked to vascular endothelial growth factor (VEGF) expression in pancreatic cancer cells. RNA interference was used to investigate the role of Sp family proteins on regulation of VEGF expression and proliferation of Panc-1 pancreatic cancer cells. Using a series of constructs containing VEGF promoter inserts, it was initially shown that Sp1 and Sp3 were required for transactivation, and this was primarily dependent on proximal GC-rich motifs. We also showed that Sp4 was expressed in Panc-1 cells, and RNA interference assays suggested that Sp4 cooperatively interacted with Sp1 and Sp3 to activate VEGF promoter constructs in these cells. However, the relative contributions of Sp proteins to VEGF expression were variable among different pancreatic cancer cell lines. Small inhibitory RNAs for Sp3, but not Sp1 or Sp4, inhibited phosphorylation of retinoblastoma protein, blocked G(0)/G(1) --> S-phase progression, and up-regulated p27 protein/promoter activity of Panc-1 cells; similar results were observed in other pancreatic cancer cells, suggesting that Sp3-dependent growth of pancreatic cancer cells is caused by inhibition of p27 expression.
引用
收藏
页码:6740 / 6749
页数:10
相关论文
共 58 条
[1]   Small inhibitory RNA duplexes for Sp1 mRNA block basal and estrogen-induced gene expression and cell cycle progression in MCF-7 breast cancer cells [J].
Abdelrahim, M ;
Samudio, I ;
Smith, R ;
Burghardt, R ;
Safe, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (32) :28815-28822
[2]  
Ahlgren JD, 1996, SEMIN ONCOL, V23, P241
[3]  
[Anonymous], CANC FACTS FIG 2003
[4]  
[Anonymous], 1996, Cancer epidemiology and prevention
[5]   Pancreatic cancer biology and genetics [J].
Bardeesy, N ;
DePinho, RA .
NATURE REVIEWS CANCER, 2002, 2 (12) :897-909
[6]  
Bardin JA, 1997, AM J IND MED, V32, P240, DOI 10.1002/(SICI)1097-0274(199709)32:3<240::AID-AJIM9>3.0.CO
[7]  
2-0
[8]   ABNORMALITIES OF THE P53 TUMOR SUPPRESSOR GENE IN HUMAN PANCREATIC-CANCER [J].
BARTON, CM ;
STADDON, SL ;
HUGHES, CM ;
HALL, PA ;
OSULLIVAN, C ;
KLOPPEL, G ;
THEIS, B ;
RUSSELL, RCG ;
NEOPTOLEMOS, J ;
WILLIAMSON, RCN ;
LANE, DP ;
LEMOINE, NR .
BRITISH JOURNAL OF CANCER, 1991, 64 (06) :1076-1082
[9]   Sp1 and kruppel-like factor family of transcription factors in cell growth regulation and cancer [J].
Black, AR ;
Black, JD ;
Azizkhan-Clifford, J .
JOURNAL OF CELLULAR PHYSIOLOGY, 2001, 188 (02) :143-160
[10]   Regulation of the activity of Sp1-related transcription factors [J].
Bouwman, P ;
Philipsen, S .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2002, 195 (1-2) :27-38